These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38523129)

  • 21. The association between different hypoglycemic regimens and postoperative diabetic macular edema after vitrectomy in the Japanese patients with proliferative diabetic retinopathy.
    Lei C; Zhang Y; Zhang M
    Front Endocrinol (Lausanne); 2022; 13():764254. PubMed ID: 35937830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Severity of diabetic macular edema (DME) in Seine St Denis among patients treated by anti-VEGF].
    Stéphan S; Fajnkuchen F; Addou-Regnard M; Grenet T; Nghiem-Buffet S; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2014 Nov; 37(9):717-21. PubMed ID: 25308789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VEGF-A gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema.
    Tetikoğlu M; Yüksel Z; Aktas S; Sağdik HM; Özcura F
    Int Ophthalmol; 2018 Dec; 38(6):2381-2388. PubMed ID: 29030794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
    Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR;
    JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
    Bressler SB; Qin H; Melia M; Bressler NM; Beck RW; Chan CK; Grover S; Miller DG;
    JAMA Ophthalmol; 2013 Aug; 131(8):1033-40. PubMed ID: 23807371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oct biomarkers of treatment-naive diabetic macular edema in patients with non-proliferative and proliferative diabetic retinopathy.
    Turkseven Kumral E; Ercalık NY; Alpogan O; Yenerel NM; Ozcelik Kose A; Ozturk Y; Acar ZA
    Eur J Ophthalmol; 2022 Sep; ():11206721221128674. PubMed ID: 36131383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current and Future Pharmacologic Therapies for Diabetic Retinopathy.
    Villegas VM; Schwartz SG
    Curr Pharm Des; 2018; 24(41):4903-4910. PubMed ID: 30706803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.
    Vail D; Callaway NF; Ludwig CA; Saroj N; Moshfeghi DM
    Am J Ophthalmol; 2019 Nov; 207():378-384. PubMed ID: 31194953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden of diabetic macular oedema in patients receiving antivascular endothelial growth factor therapy in South Korea: a healthcare resource use and cost analysis.
    Jeon HL; Lee H; Yoon D; Lee Y; Kim JH; Jee D; Shin JY
    BMJ Open; 2020 Dec; 10(12):e042484. PubMed ID: 33376178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy.
    Li Y; Yu Y; VanderBeek BL
    Eye (Lond); 2020 May; 34(5):934-941. PubMed ID: 31586167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is immediate treatment necessary for diabetic macular edema after pars plana vitrectomy for tractional complications of proliferative diabetic retinopathy?
    Behera UC; Das T; Sivaprasad S; Rani PK; Raman R; Agarwal M; Agarwal T; Sahu S; Vaidya H; Panchal B;
    Int Ophthalmol; 2021 Nov; 41(11):3607-3614. PubMed ID: 34170479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. American Society of Retina Specialists Clinical Practice Guidelines on the Management of Nonproliferative and Proliferative Diabetic Retinopathy without Diabetic Macular Edema.
    Yonekawa Y; Modi YS; Kim LA; Skondra D; Kim JE; Wykoff CC
    J Vitreoretin Dis; 2020 Mar; 4(2):125-135. PubMed ID: 34308094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combination therapy in patients with concomitant macular edema and proliferative diabetic retinopathy].
    Khomyakova EN; Ryabtseva AA; Sergushev SG; Grishina EE
    Vestn Oftalmol; 2019; 135(6):67-72. PubMed ID: 32015310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema.
    Srividya G; Jain M; Mahalakshmi K; Gayathri S; Raman R; Angayarkanni N
    Eye (Lond); 2018 Apr; 32(4):820-829. PubMed ID: 29303154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index.
    Fenwick EK; Xie J; Pesudovs K; Ratcliffe J; Chiang PP; Finger RP; Lamoureux EL
    Clin Exp Optom; 2012 May; 95(3):362-70. PubMed ID: 22537275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study.
    Zhang W; Zhao G; Fan W; Zhao T
    BMC Ophthalmol; 2021 Apr; 21(1):160. PubMed ID: 33789617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture.
    Arevalo JF; Sanchez JG; Lasave AF; Wu L; Maia M; Bonafonte S; Brito M; Alezzandrini AA; Restrepo N; Berrocal MH; Saravia M; Farah ME; Fromow-Guerra J; Morales-Canton V
    J Ophthalmol; 2011; 2011():584238. PubMed ID: 21584260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy.
    O'Fee JR; Juliano J; Moshfeghi AA
    Graefes Arch Clin Exp Ophthalmol; 2022 Jul; 260(7):2191-2200. PubMed ID: 35192029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
    Maturi RK; Glassman AR; Josic K; Baker CW; Gerstenblith AT; Jampol LM; Meleth A; Martin DF; Melia M; Punjabi OS; Rofagha S; Salehi-Had H; Stockdale CR; Sun JK;
    JAMA; 2023 Feb; 329(5):376-385. PubMed ID: 36749332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.